BioAtla (BCAB) Net Margin (2020 - 2025)

BioAtla's Net Margin history runs 4 years deep, the most recent figure standing at 459.1% for Q4 2025.

• On a quarterly basis, Net Margin changed N/A year-over-year to 459.1% in Q4 2025; TTM through Dec 2025 was 524.88%, a 423133.0% increase from a year earlier, with the FY2025 full-year figure at 8719.7%, down 714489.0% from the prior year.
• Net Margin fell to 459.1% in Q4 2025 per BCAB's latest filing, from 107.71% in the prior quarter.
• Across five years, Net Margin topped out at 107.71% in Q3 2024 and bottomed at 12152.4% in Q2 2021.
• The 3-year median for Net Margin is 459.1% (2025), against an average of 4239.74%.
• Biggest YoY gain for Net Margin was 887766 bps in 2021; the steepest drop was 887766 bps in 2021.
• Year by year, Net Margin stood at 12152.4% in 2021, then surged by 99 bps to 107.71% in 2024, then sank by 326 bps to 459.1% in 2025.
• Per Business Quant, the three latest BCAB Net Margin figures stand at 459.1% (Q4 2025), 107.71% (Q3 2024), and 12152.4% (Q2 2021).